Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Prenatal drug exposure: infant and toddler outcomes.

Bandstra ES, Morrow CE, Mansoor E, Accornero VH.

J Addict Dis. 2010 Apr;29(2):245-58. doi: 10.1080/10550881003684871. Review.

PMID:
20407980
2.

Early development of infants exposed to drugs prenatally.

Eyler FD, Behnke M.

Clin Perinatol. 1999 Mar;26(1):107-50, vii. Review.

PMID:
10214546
3.

Maintenance agonist treatments for opiate-dependent pregnant women.

Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M.

Cochrane Database Syst Rev. 2013 Dec 23;(12):CD006318. doi: 10.1002/14651858.CD006318.pub3. Review.

PMID:
24366859
4.

Prenatal cocaine exposure, child development, and the compromising effects of cumulative risk.

Tronick EZ, Beeghly M.

Clin Perinatol. 1999 Mar;26(1):151-71. Review.

PMID:
10214547
5.

Methadone and buprenorphine treatment during pregnancy: what are the effects on infants?

Pritham UA, Troese M, Stetson A.

Nurs Womens Health. 2007 Dec;11(6):558-67. Review. No abstract available.

PMID:
18088293
6.

Neonatal and longer term management following substance misuse in pregnancy.

Mactier H.

Early Hum Dev. 2013 Nov;89(11):887-92. doi: 10.1016/j.earlhumdev.2013.08.024. Epub 2013 Oct 7. Review.

PMID:
24113212
7.

Neonatal opioid withdrawal syndrome.

Sutter MB, Leeman L, Hsi A.

Obstet Gynecol Clin North Am. 2014 Jun;41(2):317-34. doi: 10.1016/j.ogc.2014.02.010. Review.

PMID:
24845493
8.

Methadone during pregnancy: the search for a valid animal model.

Hutchings DE, Zmitrovich A, Church S, Malowany D.

Ann Ist Super Sanita. 1993;29(3):439-44. Review.

PMID:
8172463
9.

Buprenorphine and methadone for opioid addiction during pregnancy.

Mozurkewich EL, Rayburn WF.

Obstet Gynecol Clin North Am. 2014 Jun;41(2):241-53. doi: 10.1016/j.ogc.2014.02.005. Epub 2014 Apr 3. Review.

PMID:
24845488
10.

Mothers on methadone: care in the NICU.

Maguire DJ.

Neonatal Netw. 2013 Nov-Dec;32(6):409-15. doi: 10.1891/0730-0832.32.6.409. Review.

PMID:
24195801
11.

Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.

Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P.

Am J Epidemiol. 2014 Oct 1;180(7):673-86. doi: 10.1093/aje/kwu190. Epub 2014 Aug 22. Review.

PMID:
25150272
12.

Follow-up of infants prenatally exposed to cocaine.

Schiller C, Allen PJ.

Pediatr Nurs. 2005 Sep-Oct;31(5):427-36. Review.

PMID:
16295162
13.

Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.

Konijnenberg C, Melinder A.

Child Neuropsychol. 2011;17(5):495-519. doi: 10.1080/09297049.2011.553591. Epub 2011 Jun 24. Review.

PMID:
21480011
14.

Issues of risk assessment: lessons from the use and abuse of drugs during pregnancy.

Hutchings DE.

Neurotoxicol Teratol. 1990 May-Jun;12(3):183-9. Review.

PMID:
2164624
15.

Methadone and buprenorphine for the management of opioid dependence in pregnancy.

Jones HE, Finnegan LP, Kaltenbach K.

Drugs. 2012 Apr 16;72(6):747-57. doi: 10.2165/11632820-000000000-00000. Review.

PMID:
22512363
16.

Prenatal cocaine exposure. Consequences for child and family.

Eyler FD, Behnke M.

J Fla Med Assoc. 1995 Sep;82(9):603-6. Review.

PMID:
7595341
17.

Effect of maternal cocaine use on the fetus and newborn: review of the literature.

Roland EH, Volpe JJ.

Pediatr Neurosci. 1989;15(2):88-94. Review.

PMID:
2699661
18.

Neurobehavioral sequelae of fetal cocaine exposure.

Singer LT, Garber R, Kliegman R.

J Pediatr. 1991 Oct;119(4):667-72. Review.

19.

The management of heroin misuse in pregnancy: time for a rethink?

Mactier H.

Arch Dis Child Fetal Neonatal Ed. 2011 Nov;96(6):F457-60. doi: 10.1136/adc.2009.181057. Epub 2010 Jun 28. Review.

PMID:
20584799
20.

Prenatal cocaine exposure and childhood psychopathology: a developmental analysis.

Scherling D.

Am J Orthopsychiatry. 1994 Jan;64(1):9-19. Review.

PMID:
7511874

Supplemental Content

Support Center